DekaBank Deutsche Girozentrale - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 1 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of NOVAVAX INC
ValueSharesWeighting
Q1 2019$185,000
-2.6%
123,100
+21.8%
0.00%0.0%
Q4 2018$190,000
+2.7%
101,100
-17.9%
0.00%0.0%
Q3 2018$185,000
+12.1%
123,1000.0%0.00%0.0%
Q2 2018$165,000
-34.5%
123,1000.0%0.00%
-50.0%
Q1 2018$252,000
+98.4%
123,100
-2.0%
0.00%
+100.0%
Q4 2017$127,0000.0%125,6000.0%0.00%0.0%
Q3 2017$127,000
-11.8%
125,6000.0%0.00%0.0%
Q2 2017$144,000
-8.9%
125,6000.0%0.00%0.0%
Q1 2017$158,000
-10.7%
125,600
-7.7%
0.00%
-50.0%
Q4 2016$177,000
-31.7%
136,100
+8.4%
0.00%
-33.3%
Q3 2016$259,000
-71.3%
125,6000.0%0.00%
-70.0%
Q2 2016$901,000
+50.9%
125,600
+8.2%
0.01%
+42.9%
Q1 2016$597,000
-47.9%
116,100
-15.3%
0.01%
-46.2%
Q4 2015$1,145,000
+19.9%
137,100
+1.5%
0.01%
+8.3%
Q3 2015$955,000
-34.3%
135,100
+3.5%
0.01%
-29.4%
Q2 2015$1,454,000
+57.0%
130,500
+16.5%
0.02%
+41.7%
Q1 2015$926,000
+24.3%
112,000
-12.5%
0.01%
+33.3%
Q4 2014$745,000
+28.0%
128,000
-8.2%
0.01%
+12.5%
Q3 2014$582,000
+5.1%
139,500
+16.2%
0.01%0.0%
Q2 2014$554,000
-0.5%
120,000
-2.4%
0.01%
-11.1%
Q1 2014$557,000
-9.3%
123,000
+3.4%
0.01%
-10.0%
Q4 2013$614,000
+107.4%
119,000
+27.0%
0.01%
+100.0%
Q3 2013$296,00093,7000.01%
Other shareholders
NOVAVAX INC shareholders Q3 2023
NameSharesValueWeighting ↓
Parametrica Management Ltd 61,882$438,0002.76%
BB BIOTECH AG 8,330,000$58,893,0001.87%
Cormorant Asset Management, LP 1,600,000$11,312,0001.81%
HARVEY CAPITAL MANAGEMENT INC 623,950$4,411,0001.76%
WILLIAM HARRIS INVESTORS INC 488,666$3,455,0000.98%
Eventide Asset Management 2,097,500$14,829,0000.86%
AWM Investment Company, Inc. 400,000$2,828,0000.55%
NORTHPOINTE CAPITAL LLC 507,344$3,587,0000.47%
Rock Springs Capital Management LP 715,000$5,055,0000.41%
Opus Point Partners Management, LLC 100,000$707,0000.39%
View complete list of NOVAVAX INC shareholders